View in EDS

Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors.

Saved in:
Bibliographic Details
Title: Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors.
Authors: Dimitriou F; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; Faculty of Medicine, University of Zurich, Zurich, Switzerland. Electronic address: florentia.dimitriou@usz.ch., Orloff MM; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA., Koch Hein EC; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Departments of Medicine and Immunology, University of Toronto, Toronto, Canada; Department of Hematology and Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile., Cheng PF; Department of Oncology, Geneva University Hospital, Geneva, Switzerland., Hughes IF; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA., Simeone E; Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italy., Montazeri K; Massachusetts General Hospital, Harvard Medical School, Boston, USA., Grover P; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Mehmi I; The Angeles Clinic and Research Institute, a Cedars Sinai Affiliate, Los Angeles, CA, USA., Gerard CL; Precision Oncology Center, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Gaudy-Marqueste C; Dermatology and Skin Cancer Department, Aix-Marseille University, Marseille, France., Grob JJ; Dermatology and Skin Cancer Department, Aix-Marseille University, Marseille, France., Michielin O; Department of Oncology, Geneva University Hospital, Geneva, Switzerland., Hamid O; The Angeles Clinic and Research Institute, a Cedars Sinai Affiliate, Los Angeles, CA, USA., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, Camperdown, Australia., Sullivan R; Massachusetts General Hospital, Harvard Medical School, Boston, USA., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre, Leiden, the Netherlands., Johnson DB; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA., Ascierto PA; Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italy., Joshua AM; Department of Medical Oncology, Kinghorn Cancer Centre, St Vincent's Hospital Sydney and Garvan Institute of Medical Research, Sydney, New South Wales, Australia., Carvajal RD; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA., Butler MO; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Departments of Medicine and Immunology, University of Toronto, Toronto, Canada., Hassel JC; Heidelberg University, Medical Faculty Heidelberg, Department of Dermatology and National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Hospital Heidelberg, Heidelberg, Germany., Dummer R; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; Faculty of Medicine, University of Zurich, Zurich, Switzerland.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Jan; Vol. 214, pp. 115161. Date of Electronic Publication: 2024 Nov 30.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39647344
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dimitriou+F%22">Dimitriou F</searchLink>; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; Faculty of Medicine, University of Zurich, Zurich, Switzerland. Electronic address: florentia.dimitriou@usz.ch.<br /><searchLink fieldCode="AU" term="%22Orloff+MM%22">Orloff MM</searchLink>; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Koch+Hein+EC%22">Koch Hein EC</searchLink>; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Departments of Medicine and Immunology, University of Toronto, Toronto, Canada; Department of Hematology and Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Cheng+PF%22">Cheng PF</searchLink>; Department of Oncology, Geneva University Hospital, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hughes+IF%22">Hughes IF</searchLink>; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Simeone+E%22">Simeone E</searchLink>; Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Montazeri+K%22">Montazeri K</searchLink>; Massachusetts General Hospital, Harvard Medical School, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Grover+P%22">Grover P</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Mehmi+I%22">Mehmi I</searchLink>; The Angeles Clinic and Research Institute, a Cedars Sinai Affiliate, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gerard+CL%22">Gerard CL</searchLink>; Precision Oncology Center, Lausanne University Hospital (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Gaudy-Marqueste+C%22">Gaudy-Marqueste C</searchLink>; Dermatology and Skin Cancer Department, Aix-Marseille University, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Grob+JJ%22">Grob JJ</searchLink>; Dermatology and Skin Cancer Department, Aix-Marseille University, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Michielin+O%22">Michielin O</searchLink>; Department of Oncology, Geneva University Hospital, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hamid+O%22">Hamid O</searchLink>; The Angeles Clinic and Research Institute, a Cedars Sinai Affiliate, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Long+GV%22">Long GV</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, Camperdown, Australia.<br /><searchLink fieldCode="AU" term="%22Sullivan+R%22">Sullivan R</searchLink>; Massachusetts General Hospital, Harvard Medical School, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Kapiteijn+E%22">Kapiteijn E</searchLink>; Department of Medical Oncology, Leiden University Medical Centre, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Johnson+DB%22">Johnson DB</searchLink>; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.<br /><searchLink fieldCode="AU" term="%22Ascierto+PA%22">Ascierto PA</searchLink>; Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Joshua+AM%22">Joshua AM</searchLink>; Department of Medical Oncology, Kinghorn Cancer Centre, St Vincent's Hospital Sydney and Garvan Institute of Medical Research, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Carvajal+RD%22">Carvajal RD</searchLink>; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Butler+MO%22">Butler MO</searchLink>; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Departments of Medicine and Immunology, University of Toronto, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22Hassel+JC%22">Hassel JC</searchLink>; Heidelberg University, Medical Faculty Heidelberg, Department of Dermatology and National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Dummer+R%22">Dummer R</searchLink>; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; Faculty of Medicine, University of Zurich, Zurich, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2025 Jan; Vol. 214, pp. 115161. <i>Date of Electronic Publication: </i>2024 Nov 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39647344
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejca.2024.115161
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 115161
    Titles:
      – TitleFull: Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dimitriou F
      – PersonEntity:
          Name:
            NameFull: Orloff MM
      – PersonEntity:
          Name:
            NameFull: Koch Hein EC
      – PersonEntity:
          Name:
            NameFull: Cheng PF
      – PersonEntity:
          Name:
            NameFull: Hughes IF
      – PersonEntity:
          Name:
            NameFull: Simeone E
      – PersonEntity:
          Name:
            NameFull: Montazeri K
      – PersonEntity:
          Name:
            NameFull: Grover P
      – PersonEntity:
          Name:
            NameFull: Mehmi I
      – PersonEntity:
          Name:
            NameFull: Gerard CL
      – PersonEntity:
          Name:
            NameFull: Gaudy-Marqueste C
      – PersonEntity:
          Name:
            NameFull: Grob JJ
      – PersonEntity:
          Name:
            NameFull: Michielin O
      – PersonEntity:
          Name:
            NameFull: Hamid O
      – PersonEntity:
          Name:
            NameFull: Long GV
      – PersonEntity:
          Name:
            NameFull: Sullivan R
      – PersonEntity:
          Name:
            NameFull: Kapiteijn E
      – PersonEntity:
          Name:
            NameFull: Johnson DB
      – PersonEntity:
          Name:
            NameFull: Ascierto PA
      – PersonEntity:
          Name:
            NameFull: Joshua AM
      – PersonEntity:
          Name:
            NameFull: Carvajal RD
      – PersonEntity:
          Name:
            NameFull: Butler MO
      – PersonEntity:
          Name:
            NameFull: Hassel JC
      – PersonEntity:
          Name:
            NameFull: Dummer R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2025 Jan
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1879-0852
          Numbering:
            – Type: volume
              Value: 214
          Titles:
            – TitleFull: European journal of cancer (Oxford, England : 1990)
              Type: main
ResultId 1